Zimbabwe has turned down a major American health deal worth $367m (272 million pounds) over five years over Washington's request for sensitive information.
The decision came to light after a internal memorandum dated December was leaked, which showed President Emmerson Mnangagwa believed the agreement was "skewed".
An official representative has since stated that the US was seeking biological samples for research and profit but was unwilling to guarantee the benefits from any future vaccines.
"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had furnished more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for further dialogue to secure a agreement suitable to both sides so the country's vital HIV treatment initiative can proceed.
Wider Context
This development follows a comparable situation in neighbouring Kenya, where a court suspended a similar deal with the US following concerns were raised about the security of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
USAID had overseen assistance for the American government, but Trump argued its spending was "wasteful" and his government was seeking direct bilateral deals to boost openness and responsibility.
According to reports, 16 nations in Africa have so far signed these new health pacts, constituting over $18.3bn of fresh investment.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration could have provided significant benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy through US-supported initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"Our nation was requested to surrender its genetic material and health information indefinitely, with no equivalent assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that shared data," he stated.
"Put simply, our country would supply the raw materials for medical research without any certainty that the end products would be accessible to our citizens if a future health crisis arise."
National Interest and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one deals were disrupting frameworks previously set up through the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing system designed to deal with potential global health emergencies.
"This mechanism is intended to ensure that when a country contributes its information, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We are open to ongoing discussions with our American counterparts on how future collaboration could be arranged in a way that honours the independence and dignity of both nations."
Medical Community Response
Medical experts expressed it understood the official position, but suggested that negotiations need to persist since a large portion of the country's Aids initiatives depended on external financing.
"In cases where technical issues exist, such as those involving data governance or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," it said.
The halted deal highlights the complex debate between receiving crucial international aid and safeguarding a country's data in an increasingly interconnected world.